|
antibody across view
238
|
animal bioassay endpoint crossview |
2016-09-15 |
2016-09-15 |
|
Antigen-Specific IgM Antibody Response (PFOS) - extra
609
|
Data pivot (animal bioassay) |
2016-07-14 |
2020-04-01 |
|
Autoimmunity incidence relative to cumulative PFOA (lag and no lag)
421
|
Data pivot (epidemiology) |
2016-01-03 |
2020-04-01 |
|
Autoimmunity: ulcerative colitis (lag and no-lag)
497
|
Data pivot (epidemiology) |
2016-02-26 |
2020-04-01 |
|
Cell phenotyping: B cells
683
|
Data pivot (animal bioassay) |
2016-10-03 |
2020-04-01 |
|
Cell phenotyping: B cells (B220 or CD19)
362
|
Data pivot (animal bioassay) |
2015-11-29 |
2020-04-01 |
|
Cell phenotyping: Macrophages and antigen-presenting cells
526
|
Data pivot (animal bioassay) |
2016-03-16 |
2020-04-01 |
|
Cell phenotyping: NK cells (CD 16, NK 1.1)
364
|
Data pivot (animal bioassay) |
2015-11-30 |
2020-04-01 |
|
Cell phenotyping: T cells (CD4)
326
|
Data pivot (animal bioassay) |
2015-09-02 |
2020-04-01 |
|
Cell phenotyping: T cells (CD8)
359
|
Data pivot (animal bioassay) |
2015-11-29 |
2020-04-01 |
|
Cell phenotyping: T cells DN(CD4-/CD8-)
361
|
Data pivot (animal bioassay) |
2015-11-29 |
2020-04-01 |
|
Cell phenotyping: T cells DP(CD4+/CD8+)
360
|
Data pivot (animal bioassay) |
2015-11-29 |
2020-04-01 |
|
Cellularity-Spleen (PFOA)
313
|
Data pivot (animal bioassay) |
2015-08-11 |
2020-04-01 |
|
Cellularity-Spleen (PFOS)
314
|
Data pivot (animal bioassay) |
2015-08-11 |
2020-04-01 |
|
Cellularity-Thymus (PFOA)
315
|
Data pivot (animal bioassay) |
2015-08-11 |
2020-04-01 |
|
Cellularity-Thymus (PFOS)
316
|
Data pivot (animal bioassay) |
2015-08-11 |
2020-04-01 |
|
Circulating Immunoglobulins - total IgG
380
|
Data pivot (animal bioassay) |
2015-12-08 |
2020-04-01 |
|
Circulating Immunoglobulins - total IgM
381
|
Data pivot (animal bioassay) |
2015-12-08 |
2020-04-01 |
|
Cytokine - IFN gamma (PFOA and PFOS)
302
|
Data pivot (animal bioassay) |
2015-07-29 |
2020-04-01 |
|
Cytokine - IL1 (PFOA and PFOS)
322
|
Data pivot (animal bioassay) |
2015-09-01 |
2020-04-01 |
|
Cytokine - IL10 (PFOA and PFOS)
320
|
Data pivot (animal bioassay) |
2015-08-31 |
2020-04-01 |
|
Cytokine - IL2 (PFOA and PFOS)
319
|
Data pivot (animal bioassay) |
2015-08-31 |
2020-04-01 |
|
Cytokine - IL4 (PFOA and PFOS)
318
|
Data pivot (animal bioassay) |
2015-08-12 |
2020-04-01 |
|
Cytokine - IL5 (PFOA and PFOS)
363
|
Data pivot (animal bioassay) |
2015-11-29 |
2020-04-01 |
|
Cytokine - IL6 (PFOA and PFOS)
321
|
Data pivot (animal bioassay) |
2015-08-31 |
2020-04-01 |
|
Cytokine - TNF-alpha (PFOA and PFOS)
317
|
Data pivot (animal bioassay) |
2015-08-11 |
2020-04-01 |
|
Delayed-Type Hypersensitivity (DTH) (PFOA and PFOS)
299
|
Data pivot (animal bioassay) |
2015-07-24 |
2020-04-01 |
|
Figure A3-1: All epidemiology study RoB heatmap
119
|
risk of bias heatmap |
2015-12-03 |
2020-08-25 |
|
Figure A3-2: All experimental animal study RoB heatmap
103
|
risk of bias heatmap |
2015-06-23 |
2020-08-25 |
|
Figure A3-3: All wildlife study RoB heatmap
163
|
risk of bias heatmap |
2016-03-13 |
2020-08-25 |
|
Figure A3-4: All In vitro study RoB heatmap
118
|
risk of bias heatmap |
2015-12-02 |
2020-08-25 |
|
Figure D01: Vaccine-Specific Antibody Response (by maternal exposure) presented as beta
340
|
Data pivot (epidemiology) |
2015-11-02 |
2020-04-01 |
|
Figure D02: Vaccine-Specific Antibody Response (maternal exposure) as % difference antibody per 2-fold increase PFOA or PFOS
396
|
Data pivot (epidemiology) |
2015-12-19 |
2020-04-01 |
|
Figure D03: Vaccine-Specific Antibody Response (child exposure) as % difference antibody per 2-fold increase PFOA or PFOS
395
|
Data pivot (epidemiology) |
2015-12-19 |
2020-04-01 |
|
Figure D04: Vaccine-Specific Antibody Response (adult exposure) presented as beta
358
|
Data pivot (epidemiology) |
2015-11-29 |
2020-04-01 |
|
Figure D05: Vaccine-Specific Antibody Response (adult exposure) presented as % change following vaccination
348
|
Data pivot (epidemiology) |
2015-11-24 |
2020-04-01 |
|
Figure D06: Antigen-Specific IgM Antibody Response (PFOA)
289
|
Data pivot (animal bioassay) |
2015-07-21 |
2020-04-01 |
|
Figure D07: Antigen-Specific IgG Antibody Response (PFOA)
290
|
Data pivot (animal bioassay) |
2015-07-21 |
2020-04-01 |
|
Figure D08: Antigen-Specific IgM Antibody Response (PFOS)
288
|
Data pivot (animal bioassay) |
2015-07-21 |
2020-04-01 |
|
Figure D09: Antigen-Specific IgG Antibody Response (PFOS)
291
|
Data pivot (animal bioassay) |
2015-07-23 |
2020-04-01 |
|
Figure D10: Risk of Bias - PFOA and PFOS antibody response in humans
113
|
risk of bias barchart |
2015-10-26 |
2020-08-25 |
|
Figure D11: RoB Heatmap - PFOA and PFOS antibody response in Humans
111
|
risk of bias heatmap |
2015-10-20 |
2020-08-25 |
|
Figure D12: Risk of Bias - PFOA Antibody response in Animals
108
|
risk of bias barchart |
2015-09-15 |
2020-08-25 |
|
Figure D13: RoB Heatmap - PFOA antibody response in Animals
104
|
risk of bias heatmap |
2015-07-09 |
2020-08-25 |
|
Figure D14: Risk of Bias - PFOS Antibody response in Animals
115
|
risk of bias barchart |
2015-11-24 |
2020-08-25 |
|
Figure D15: RoB Heatmap - PFOS antibody response in Animals
114
|
risk of bias heatmap |
2015-10-28 |
2020-08-25 |
|
Figure D16: Infectious Disease general (PFOA and PFOS)
410
|
Data pivot (epidemiology) |
2015-12-21 |
2020-04-01 |
|
Figure D17: Infectious Disease: Granum 2013 (analyzed as episodes for PFOA and PFOS levels)
503
|
Data pivot (epidemiology) |
2016-02-28 |
2020-04-01 |
|
Figure D18: Hospitalizations for infectious disease (PFOA and PFOS)
427
|
Data pivot (epidemiology) |
2016-01-06 |
2020-04-01 |
|
Figure D19: Disease Resistance in Animal Studies (PFOA and PFOS)
408
|
Data pivot (animal bioassay) |
2015-12-21 |
2020-04-01 |
|
Figure D20: Risk of Bias - PFOA and PFOS infectious disease in humans
121
|
risk of bias barchart |
2015-12-22 |
2020-08-25 |
|
Figure D21: RoB Heatmap - PFOA and PFOS infectious disease in humans
120
|
risk of bias heatmap |
2015-12-22 |
2020-08-25 |
|
Figure D22: RoB Heatmap - PFOA and PFOS Disease Resistance in Animals
156
|
risk of bias heatmap |
2016-03-02 |
2020-08-25 |
|
Figure D23: Natural Killer (NK) Cell Activity in Animals (PFOA and PFOS)
293
|
Data pivot (animal bioassay) |
2015-07-23 |
2020-04-01 |
|
Figure D24: In Vitro: Natural Killer (NK) Cell Activity
398
|
Data pivot (in vitro) |
2015-12-20 |
2020-04-01 |
|
Figure D25: Risk of Bias - PFOS NK cell activity in Animals
116
|
risk of bias barchart |
2015-11-28 |
2020-08-25 |
|
Figure D26: RoB Heatmap - PFOS NK cell activity in Animals
117
|
risk of bias heatmap |
2015-11-28 |
2020-08-25 |
|
Figure D27: Hypersensitivity - Asthma in children (current PFOA levels)
513
|
Data pivot (epidemiology) |
2016-03-07 |
2020-04-01 |
|
Figure D28: Hypersensitivity - Asthma in children (current PFOS levels)
514
|
Data pivot (epidemiology) |
2016-03-07 |
2020-04-01 |
|
Figure D29: Hypersensitivity - Airway Response Measures
418
|
Data pivot (animal bioassay) |
2015-12-31 |
2020-04-01 |
|
Figure D30: Hypersensitivity - Specific IgE
382
|
Data pivot (animal bioassay) |
2015-12-08 |
2020-04-01 |
|
Figure D31: Circulating Immunoglobulins - total IgE
379
|
Data pivot (animal bioassay) |
2015-12-08 |
2020-04-01 |
|
Figure D32: Risk of Bias - asthma in children with current PFOA and PFOS levels
158
|
risk of bias barchart |
2016-03-09 |
2020-08-25 |
|
Figure D33: RoB Heatmap - asthma in children with current PFOA and PFOS levels
159
|
risk of bias heatmap |
2016-03-09 |
2020-08-25 |
|
Figure D34: RoB Heatmap - PFOA and PFOS hypersensitivity response in Humans
124
|
risk of bias heatmap |
2016-01-03 |
2020-08-25 |
|
Figure D35: Risk of Bias - Hypersensitivity studies in Animals
123
|
risk of bias barchart |
2015-12-31 |
2020-08-25 |
|
Figure D36: RoB Heatmap - Hypersenstivity studies in Animals
122
|
risk of bias heatmap |
2015-12-31 |
2020-08-25 |
|
Figure D37: Autoimmunity incidence relative to cumulative PFOA (10-year lag)
498
|
Data pivot (epidemiology) |
2016-02-26 |
2020-04-01 |
|
Figure D38: Risk of Bias - PFOA autoimmunity - ulcerative colitis in Humans
127
|
risk of bias barchart |
2016-01-03 |
2020-08-25 |
|
Figure D39: RoB Heatmap - PFOA autoimmunity - ulcerative colitis in Humans
126
|
risk of bias heatmap |
2016-01-03 |
2020-08-25 |
|
Hypersensitivity - Asthma
419
|
Data pivot (epidemiology) |
2016-01-02 |
2020-04-01 |
|
Hypersensitivity - IgE
426
|
Data pivot (epidemiology) |
2016-01-06 |
2020-04-01 |
|
Hypersensitivity - Wheeze with PFOA or PFOS Exposure
420
|
Data pivot (epidemiology) |
2016-01-02 |
2020-04-01 |
|
In Vitro: cell viability (PFOA and PFOS)
525
|
Data pivot (in vitro) |
2016-03-15 |
2020-04-01 |
|
In Vitro: Cytokine - IFN gamma
404
|
Data pivot (in vitro) |
2015-12-20 |
2020-04-01 |
|
In Vitro: Cytokine - IL10
402
|
Data pivot (in vitro) |
2015-12-20 |
2020-04-01 |
|
In Vitro: Cytokine - IL4
400
|
Data pivot (in vitro) |
2015-12-20 |
2020-04-01 |
|
In Vitro: Cytokine - IL6 (PFOA and PFOS)
399
|
Data pivot (in vitro) |
2015-12-20 |
2020-04-01 |
|
In Vitro: Cytokine - IL8
401
|
Data pivot (in vitro) |
2015-12-20 |
2020-04-01 |
|
In Vitro: Cytokine - TNF alpha
403
|
Data pivot (in vitro) |
2015-12-20 |
2020-04-01 |
|
In Vitro: Lymphoproliferation - ConA
378
|
Data pivot (in vitro) |
2015-12-07 |
2020-04-01 |
|
In Vitro: Lymphoproliferation - LPS
397
|
Data pivot (in vitro) |
2015-12-20 |
2020-04-01 |
|
Infectious Disease - otitis media (PFOA and PFOS)
411
|
Data pivot (epidemiology) |
2015-12-21 |
2020-04-01 |
|
Lymphoproliferation - ConA
323
|
Data pivot (animal bioassay) |
2015-09-01 |
2020-04-01 |
|
Lymphoproliferation - LPS
325
|
Data pivot (animal bioassay) |
2015-09-02 |
2020-04-01 |
|
Neutrophil, Monocyte, Granulocyte Phagocytosis (PFOA and PFOS)
300
|
Data pivot (animal bioassay) |
2015-07-27 |
2020-04-01 |
|
Risk of Bias - PFOA and PFOS hypersensitivity response in Humans
125
|
risk of bias barchart |
2016-01-03 |
2020-08-25 |
|
RoB Heatmap - PFOA NK cell activity in Animals
157
|
risk of bias heatmap |
2016-03-02 |
2020-08-25 |
|
Spleen weight (PFOA)
304
|
Data pivot (animal bioassay) |
2015-07-29 |
2020-04-01 |
|
Spleen weight (PFOS)
306
|
Data pivot (animal bioassay) |
2015-08-06 |
2020-04-01 |
|
Spleen weight: absolute (PFOA and PFOS)
406
|
Data pivot (animal bioassay) |
2015-12-20 |
2020-04-01 |
|
Test - Antibody cross view
107
|
animal bioassay endpoint crossview |
2015-07-24 |
2016-04-04 |
|
Test-Vaccine-Specific Antibody Response (by child exposure) presented as % difference antibody per 2-fold increase PFOA
572
|
Data pivot (epidemiology) |
2016-05-25 |
2020-04-01 |
|
Thymus weight (PFOA)
301
|
Data pivot (animal bioassay) |
2015-07-27 |
2020-04-01 |
|
Thymus weight (PFOS)
303
|
Data pivot (animal bioassay) |
2015-07-29 |
2020-04-01 |
|
Thymus weight: absolute (PFOS)
407
|
Data pivot (animal bioassay) |
2015-12-20 |
2020-04-01 |
|
Vaccine-Specific Antibody Response (child exposure) as % difference antibody per 2-fold increase - extra PFOA
610
|
Data pivot (epidemiology) |
2016-07-14 |
2020-04-01 |
|
Vaccine-Specific Antibody Response (child exposure) as % difference antibody per 2-fold increase - Extra PFOS
611
|
Data pivot (epidemiology) |
2016-07-14 |
2020-04-01 |